tradingkey.logo

Caris Life Sciences Inc

CAI

33.660USD

+0.540+1.63%
Close 09/16, 16:00ETQuotes delayed by 15 min
9.46BMarket Cap
LossP/E TTM
Quarterly
Quarterly+Annual
Quarterly
Annual
YOY
Hide blank rows
FY2025Q2
FY2025Q1
Total revenue
--181.40M
--120.92M
Revenue
----
--120.92M
Cost of revenue
--67.71M
--63.85M
Operating expenses
--199.39M
--178.87M
R&D expenses
--25.05M
--23.07M
Depreciation, depletion, and amortization
--6.41M
--7.04M
Other operating expenses
----
--1.00K
Operating profit
---17.99M
---57.95M
Net non-operating interest income (expenses)
Non-operating interest income
--1.62M
--503.00K
Non-operating interest expense
--19.21M
--12.78M
Special income (expenses)
---35.80M
---32.33M
Other non-operating income (expenses)
---411.00K
---17.00K
Income before tax
---71.79M
---102.58M
Income tax
--0.00
--0.00
Income after tax
---71.79M
---102.58M
Net income from continuous operations
---71.79M
---102.58M
Net income attributable to controlling interests
---517.20M
---127.04M
Preferred share dividend
--384.44M
--24.46M
Net income attributable to common shareholders
---517.20M
---127.04M
Basic earnings per share
---1.84
---0.46
Diluted earnings per share
---1.84
---0.46
Dividend per share
--0.00
--0.00
Currency unit
USD
USD
Audit opinions
--
--
KeyAI